Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated radiolabeled monoclonal antibody therapy followed by high-dose chemotherapy and autologous stem cell transplantation in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma | Phase 1 | Status: COMPLETED